Tuesday, February 24, 2015

EG's Journey For A Cure Continues in 2015

During the week, Eric Gelber a long-time supporter of the MMRF is just a regular hard working businessman, doting father, and loving husband. But come certain weekends, you’ll find Eric transform into an amazing ultra-marathon runner who will stop at nothing in his quest to raise funds to combat multiple myeloma, an as yet incurable blood cancer that took the life of his good friend Anita. 
RELENTLESS JOURNEY: Eric has completed unprecedented runs all around the country to raise funds and awareness for the MMRF. In 2011, Eric ran the Catskill 155, a 155-mile solo run through the Catskill Mountains. Then, in 2012, Eric completed Badwater, a 135-mile run from Death Valley to Mt. Whitney in temperatures often reaching above 120 degrees and completed a double non-stop crossing of the Grand Canyon. In 2013 he ran for 48 straight hours in New York City’s Central Park covering a total of 165 miles and as if that wasn’t enough he ran for over 2 days in Central Park in 2014 completing more than 29 loops totaling 176 miles. In total, Eric has raised over $475 thousand for the MMRF. 
AUDACIOUS CHALLENGE: This year Eric is heading back to Death Valley to compete yet again in the “World’s Toughest Footrace” the Badwater 135 Ultramarathon.  As one of only 100 athletes from around the world invited to compete, beginning on July 28th Eric will have just 48 hours to run 135 miles through the hottest place on earth while climbing 3 mountain ranges, culminating at the Mt. Whitney Portal at over 8,000 feet. His goal is to raise $250 thousand for ground-breaking research that will bring new hope to myeloma patients. 135 miles in temperatures that often approach and even surpass 130 degrees. What keeps him going? Knowing that each dollar raised will bring us closer to improved patient treatments and, ultimately, a cure. 
POWERFUL CAUSE:Although progress has been made in treating multiple myeloma, the five-year relative survival rate remains one of the lowest of all cancers. The work of the MMRF has contributed to FDA approval of six new cancer drugs in less than a decade and doubled the life expectancy of myeloma patients – a track record that's unparalleled in the world of oncology. 
The MMRF is the world’s leading private funder of myeloma research and one of the most highly regarded cancer foundations in the world. An outstanding 90% of the total MMRF budget goes directly towards cancer research and related programming, and they are consistently recognized in the top 1% of all charities reviewed by evaluators like Charity Navigator. 

Related Posts with Thumbnails